96034-07-0

Upstream product

• 96034-08-1 2-chloro-6-methoxy-2-methyl-3,4-dihydronaphthalen-1(2H)-one 
• 13139-86-1 4-methoxyphenyl magnesium bromide 
• 96034-06-9 6-methoxy-2-(p-methoxyphenyl)-3,4-dihydronaphthalen-1(2H)-one 
• 74-88-4 methyl iodide 
• 27752-24-5 6-methoxy-2-methyl-3,4-dihydronaphthalen-1(2H)-one 
• 96034-05-8 2-formyl-6-methoxy-2-(p-methoxyphenyl)-3,4-dihydronaphthalen-1(2H)-one 
• 762-72-1 allyl-trimethyl-silane 
• 1078-19-9 6-methoxy-3,4-dihydro-1(2H)-naphthalenone 
• 16252-53-2 6-Methoxy-2-hydroxymethylen-1-tetralon 

Downstream Products

• 96043-75-3 6-methoxy-2-(p-methoxyphenyl)-2-methyl-1,2,3,4-tetrahydronaphthalen-1ζ-ol 
• 119047-56-2 1ζ-acetoxy-6-methoxy-2-(p-methoxyphenyl)-2-methyl-1,2,3,4-tetrahydronaphthalene 
• 52924-01-3 6-methoxy-1-(p-methoxyphenyl)-2-methyl-3,4-dihydronaphthalene 

Relevant academic research and scientific papers

Compounds with hydroxycarbonyl-halogenoalkyl side chain

The present invention provides a compound consisting of a moiety and a group chemically bonded to said moiety, wherein said moiety contains a compound having low activity following oral administration or its parent scaffold and said group has the followin

Antioestrogenic phenol derivatives

A phenol derivative of the formula wherein NU is a defined bis-phenolic nucleus including a hydroxyphenyl-hydroxynaphthyl; hydroxyphenyl-hydroxy-indanyl, hydroxyphenyl-hydroxybenzothienyl or di-hydroxyphenyl-ethylene or vinylene nucleus; wherein A is alky

Phenol derivatives

A phenol derivative of the formula wherein NU is a defined bis-phenolic nucleus including a hydroxyphenyl-hydroxynaphthyl; hydroxyphenyl-hydroxyindanyl, hydroxyphenyl-hydroxybenzothienyl or di-hydroxyphenyl-ethylene or vinylene nucleus; wherein A is alkylene, alkenylene or alkynylene which may be interrupted by phenylene or other linkages, wherein R1 is hydrogen, or alkyl, alkenyl, cycloalkyl, halogenoalkyl, aryl or arylalkyl, or R1 is joined to R2, and wherein X is --CONR2 --, --CSNR2 --, --NR12 CO--, --NR12 CS--, --NR12 CONR2 --, STR1 --SO2 NR2 -- or --CO--, or, when R1 is not hydrogen, is --NR12 COO--, --S--, --SO-- or --SO2 --, wherein R2 is hydrogen or alkyl, or R1 and R2 together form alkylene; wherein R12 is hydrogen or alkyl, and wherein R22 is hydrogen, cyano or nitro; or a salt thereof when appropriate. The compounds possess antioestrogenic activity and may be used for the treatment of hormone-dependent breast tumours or of anovulatory infertility.